Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /002287

Tibet Cheezheng Tibetan Medicine Co., Ltd.

002287

• SHE: 002287 • Delayed

22.74CNY -0.3%

3.35 USD

As of 26 June 2026, Tibet Cheezheng Tibetan Medicine Co., Ltd. has a market cap of $1.91B USD, ranking #7241 globally and #1802 in China. It ranks #585 in the Healthcare sector, and #25 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

7241

Country Rank

1802

Sector Rank

585

Industry Rank

Key Stats

Market Cap

$1.91BUSD

12.98B CNY

Enterprise Value

$1.65BUSD

11.18B CNY

Revenue (TTM)

$356.09MUSD

2.42B CNY

EBITDA (TTM)

$127.92MUSD

868.74M CNY

Net Income (TTM)

$98.35MUSD

667.92M CNY

EBITDA Margin

36%

Profit Margin

28%

PE Ratio

18.9

PS Ratio

5.4

PB Ratio

2.6

EV/EBITDA

12.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Haijian Xia open_in_new

Employees

3,170

Founded

1995

Website

cheezheng.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-1.3%	-0.3%	-5.9%	-9.7%	-3.6%	-4.9%	-6.9%	-13%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002287 西藏奇正藏药股份有限公司 Class A ISIN: CNE100000FM9 Shares Out.: Shares Outstanding: 566.878M¹ Shares Float: 99.875M² TV: TradingView: SZSE: 002287 SA: Stock Analysis: SHE: 002287 YF: Yahoo Finance: 002287.SZ GF: Google Finance: SHE: 002287 BA: Barron's: 002287 MS: Morningstar: XSHE: 002287	22.74 CNY	TV: TradingView: SZSE: 002287 SA: Stock Analysis: SHE: 002287 YF: Yahoo Finance: 002287.SZ GF: Google Finance: SHE: 002287 BA: Barron's: 002287 MS: Morningstar: XSHE: 002287

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tibet Cheezheng Tibetan Medicine Co., Ltd.

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculoskeletal system, nervous system, respiratory, digestive, urinary, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.81B 107.34B CNY 727%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.07B 61.6B CNY 374%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.2B 35.33B CNY 172%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.19B 28.47B CNY 119%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.26B 22.12B CNY 70%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.73B 18.55B CNY 43%	11.5	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.51B 108.92B ILS 2K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 1K%	-	United States
Cipla Ltd. NSE: CIPLA	$11.27B 1.06T INR 489%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.15B 1.05T INR 483%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.6B 7.57B EUR 350%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.54B 807.02B INR 347%	23.1	India

chevron_leftBack